AKBA
AKBA

Akebia Therapeutics Inc

NASDAQ · Biotechnology
$1.39
+0.01 (+0.72%)
Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks
Analyst Consensus
Strong Buy
11 analysts
Buy 10 91%
Hold 1 9%
Sell 0 0%
Price Target
Analyst Price Target +2,594.2% upside
Low Target $22.27
Average Target $37.45
High Target $46.32
Current Price $1.39
Current
$1.39
Target
$37.45
$22.27 $37.45 avg $46.32